Chongqing Aoli Biopharmaceutical

Chongqing Aoli Biopharmaceutical is a major Chinese GMP-certified manufacturer of commercial-scale enzymes and biochemical APIs, including pancreatin, pepsin, chondroitin sulfate sodium, and related pharma and nutraceutical ingredients. Production meets international pharmacopeia standards (CP, USP, EP, BP, JP), with mature export markets in America, Europe, and Southeast Asia. The company claims the largest domestic capacity for bulk biochemical APIs and is active as both API supplier and finished dosage manufacturer (tablets, capsules, granules). It is not developing proprietary NCE drugs or clinical-stage therapeutics.